−1.6TWD
−61.54 MTWD
4.85 MTWD
About GNT BIOTECH & MEDICALS CORP
Sector
CEO
Chia Nan Chen
Website
Headquarters
Taipei
Employees (FY)
12
Founded
2013
ISIN
TW0007427007
FIGI
BBG006H3JH85
Great Novel Therapeutics Biotech & Medicals Corp. engages in the research and development of cancer medical treatment. The company was founded by Chia Nan Chen on April 3, 2013 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 7427 is 55.6 TWD — it has increased by 1.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GNT BIOTECH & MEDICALS CORP stocks are traded under the ticker 7427.
7427 stock is 5.73% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is GNT BIOTECH & MEDICALS CORP there?
Yes, you can track GNT BIOTECH & MEDICALS CORP financials in yearly and quarterly reports right on TradingView.
7427 stock has risen by 1.16% compared to the previous week, the month change is a 10.01% rise, over the last year GNT BIOTECH & MEDICALS CORP has showed a 37.31% decrease.
7427 net income for the last quarter is −27.49 M TWD, while the quarter before that showed −34.05 M TWD of net income which accounts for 19.26% change. Track more GNT BIOTECH & MEDICALS CORP financial stats to get the full picture.
No, 7427 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 7427 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GNT BIOTECH & MEDICALS CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has 12.00 employees. See our rating of the largest employees — is GNT BIOTECH & MEDICALS CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GNT BIOTECH & MEDICALS CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GNT BIOTECH & MEDICALS CORP stock shows the neutral signal. See more of GNT BIOTECH & MEDICALS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GNT BIOTECH & MEDICALS CORP EBITDA is −59.83 M TWD, and current EBITDA margin is −1.23 K%. See more stats in GNT BIOTECH & MEDICALS CORP financial statements.